AlphaMadera
Agilon Health, Inc. (AGL)
$114.02
+0.94 (+0.83%)Delayed quote.
Price history
Daily close- Start
- $16.49
- Latest close
- $114.02
- Period change
- +591.45%
- Period low
- $7.91
- Period high
- $129.48
Key metrics
- Market cap
- $1.92B
- Volume
- 7.2K
- Average volume
- 271.9K
- 52-week range
- $7.48 – $133.04
- Beta
- 3.11
- Last dividend
- —
- EPS (TTM)
- -$6.55
- P/E ratio
- -0.70
- Revenue (TTM)
- $6.00B
- Net income (TTM)
- -$106.04M
- Total assets
- $1.57B
- Total debt
- $33.42M
- Cash and equivalents
- $174.40M
Key financials (trailing twelve months).
Company profile
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NYSE
- CEO
- Timothy O'Rourke
- Employees
- 856
- Headquarters
- Westerville, OH, US
- IPO date
- 2021-04-15
- Website
- https://agilonhealth.com
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Revenue | $5.93B | $6.06B | $4.32B |
| Gross profit | -$188.61M | $4.84M | $69.67M |
| Operating income | -$421.08M | -$292.13M | -$232.13M |
| EBITDA | -$368.86M | -$218.19M | -$167.64M |
| Net income | -$405.35M | -$260.15M | -$262.60M |
| Diluted EPS | -$24.50 | -$15.75 | -$16.00 |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $173.71M | $193.86M | $114.33M |
| Total assets | $1.27B | $1.73B | $1.74B |
| Total liabilities | $1.14B | $1.26B | $1.08B |
| Total debt | $36.81M | $43.96M | $52.31M |
| Shareholders’ equity | $126.73M | $470.95M | $661.84M |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | -$105.76M | -$57.78M | -$156.20M |
| Capital expenditure | -$13.24M | -$13.25M | -$30.82M |
| Free cash flow | -$119.00M | -$71.03M | -$187.01M |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.52B | $1.49B | $1.42B | $1.57B | $1.44B | $1.39B |
| Gross profit | $97.98M | $107.14M | $58.23M | -$97.64M | -$67.65M | -$52.43M |
| Operating income | $24.11M | $11.77M | $10.11M | -$155.76M | -$131.27M | -$116.03M |
| EBITDA | $47.40M | $11.21M | $34.92M | -$178.87M | -$101.27M | -$95.42M |
| Net income | $34.91M | $17.96M | $29.97M | -$188.88M | -$110.21M | -$104.37M |
| Diluted EPS | $1.97 | $1.04 | $1.80 | -$11.50 | -$6.75 | -$6.25 |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $174.40M | $107.18M | $139.99M | $173.71M | $171.68M | $171.42M |
| Total assets | $1.57B | $1.59B | $1.50B | $1.27B | $1.60B | $1.71B |
| Total liabilities | $1.28B | $1.36B | $1.32B | $1.14B | $1.29B | $1.30B |
| Total debt | $33.42M | $33.45M | $33.40M | $36.81M | $37.12M | $41.37M |
| Shareholders’ equity | $280.88M | $227.53M | $181.43M | $126.73M | $306.08M | $408.93M |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $49.87M | -$57.30M | $23.73M | -$20.54M | -$18.15M | -$35.09M |
| Capital expenditure | -$3.26M | -$3.45M | -$3.10M | -$17.04M | -$3.17M | -$3.25M |
| Free cash flow | $46.62M | -$60.74M | $20.63M | -$37.57M | -$21.33M | -$38.34M |